Evaluating the use and perceptions of cannabis and vaping post-cannabis legalisation in people with cystic fibrosis and CFTR-related disorder: survey results from a large Canadian adult cystic fibrosis clinic

Cannabis use was common, with a reported increase since its legalisation in this population. EVALI media attention was reported to increase awareness for potential harms associated with vaping. CF healthcare providers are well positioned to provide education and support so patients can make informed decisions about cannabis use and vaping.